Related content

Tracer Level Electrophilic Synthesis and Pharmacokinetics of the Hypoxia Tracer [ 18 F]EF5

By Eskola Olli  

Molecular Imaging and Biology, Vol. 14, Iss. 2, 2012-04 ,pp. : 205-212

Springer Publishing Company

Access to resources Recommend Favorite

Imaging of tumour hypoxia using PET and ¹⁸F-labelled tracers: biology meets technology

By Grönroos Tove   Minn Heikki  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 10, 2007-10 ,pp. : 1563-1565

Springer Publishing Company

Access to resources Recommend Favorite

Tumour hypoxia imaging with [¹⁸F]FAZA PET in head and neck cancer patients: a pilot study

By Souvatzoglou M.   Grosu A.   Röper B.   Krause B.   Beck R.   Reischl G.   Picchio M.   Machulla H.-J.   Wester H.-J.   Piert M.  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 10, 2007-10 ,pp. : 1566-1575

Springer Publishing Company

Access to resources Recommend Favorite

Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)-N-(3,3,3-[¹⁸F]trifluoropropyl)acetamide, [¹⁸F]EF3

By Mahy P.   De Bast M.   Leveque P.   Gillart J.   Labar D.   Marchand J.   Gregoire V.  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 9, 2004-09 ,pp. : 1263-1272

Springer Publishing Company

Access to resources Recommend Favorite

FDG—a marker of tumour hypoxia? A comparison with [¹⁸F]fluoromisonidazole and pO₂-polarography in metastatic head and neck cancer

By Zimny Michael   Gagel Bernd   DiMartino Ercole   Hamacher Kurt   Coenen Heinz   Westhofen Martin   Eble Michael   Buell Ulrich   Reinartz Patrick  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 33, Iss. 12, 2006-12 ,pp. : 1426-1431

Springer Publishing Company

Access to resources Recommend Favorite